Investigating satellite glial cell phenotypes and functions in the pathogenesis of Friedreich’s ataxia
|Oct 30 2025
Discovery of genetic suppressor mutations that rescue frataxin deficiency
|Oct 30 2025
Pre-clinical assessment of protein replacement therapy in the central nervous system of Friedreich’s ataxia mouse models
|Oct 28 2025
Advancing FA Treatment: Exploring the Pharmacology of Neonatal Cardiac Progenitor Cells for Cardiac and Neuroprotection
|Oct 12 2025
Exploring the Role of Extracellular Traps in the Pathogenesis of Friedreich’s Ataxia
|Nov 4 2024
Understanding the Pathogenesis of Friedreich’s Ataxia by Single-Cell Integration of Gene Expression, Epigenetics and Connectivity in the Cerebellar Nuclei
|Oct 30 2024
Enhancing Gene Therapy Delivery to the Brain via Human Blood-Brain Barrier Receptors
|Oct 27 2024
Mitochondrial Enzyme Activity and Biomarker Evaluation in FA Treatment (MEABET-FA)
|Oct 20 2023
Role of the Thromboxane-Prostanoid Receptor in FRDA Cardiomyopathy
|Oct 19 2023
Hematopoietic Stem Cell Transplantation in FRDA: Proof-of-concept studies using novel conditioning regimen and the YG8s(GAA)>800 mouse
|Oct 19 2022
Illuminating how SynGRs liberate gene expression from heterochromatin
|Oct 19 2022
Engineering adeno-associated viral vectors to evade immune responses